S1 Biopharma, Inc. (NASDAQ: SXB) fled a registration statement on Form S-1 with the SEC for maximum $40.25 million IPO ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE